4 April 2018
Circulating tumor DNA in esophageal and rectal cancer patients undergoing chemoradiation therapy
Hans de Wilt and Bastiaan Klarenbeek, theme Tumors of the digestive tract, received a research grant of 80.000 euro from the 'Bergh in het Zadel' foundation to study circulating tumor DNA in their patients. Both surgeons are involved in the multimodality treatment of rectal and esophageal cancer patients and are interested in these 'liquid biopsies' during and after treatment. In close collaboration with Prof. Ligtenberg from the department of genetics, they will study circulating tumor DNA before the start of chemoradiation of these patients and compare this during and after treatment. The results might give insight in the response of the tumor on chemoradiation therapy, but also might reflect prognosis of patients after following surgical treatment.-
Want to know more about these subjects? Click on the buttons below for more news.